*	OR T2 T3
R1	Has_value Arg1:T4 Arg2:T5	
R2	Has_value Arg1:T6 Arg2:T8	
R3	Has_value Arg1:T9 Arg2:T10	
*	OR T11 T12
R4	Has_value Arg1:T15 Arg2:T16	
R5	Has_value Arg1:T13 Arg2:T14	
*	OR T13 T15
R6	AND Arg1:T17 Arg2:T18	
R7	Has_temporal Arg1:T17 Arg2:T19	
R8	Has_value Arg1:T21 Arg2:T22	
R9	Has_value Arg1:T23 Arg2:T24	
*	OR T21 T23
R10	AND Arg1:T17 Arg2:T21	
*	OR T13 T17
T1	Condition 26 39	heart failure
T2	Person 41 44	men
T3	Person 49 54	women
T4	Person 56 60	aged
T5	Value 61 70	>18 years
T7	Condition 0 11	Symptomatic
T6	Measurement 111 144	New York Heart Association (NYHA)
T8	Value 73 103	Functional class II, III or IV
T9	Measurement 146 180	Left ventricular ejection fraction
T10	Value 181 185	<35%
T11	Condition 187 195;212 220	Ischemic etiology
T12	Condition 200 220	nonischemic etiology
T13	Measurement 222 254	Type B natriuretic peptide (BNP)
T14	Value 255 265	>150 pg/ml
T15	Measurement 270 297	pro-BNP [N-terminal-proBNP]
T16	Value 298 311	= 600 pg / ml
T17	Procedure 335 347	hospitalized
T18	Condition 352 374	cardiac decompensation
T19	Temporal 375 405	within the preceding 12 months
T21	Measurement 407 410	BNP
T22	Value 411 421	>100 pg/ml
T23	Measurement 426 443	N-terminal-proBNP
T24	Value 444 457	= 400 pg / ml
